Cooper Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Sell
2,875
-606
-17% -$291K 0.12% 129
2026
Q1
$1.71M Buy
3,481
+1,000
+40% +$543K 0.17% 104
2025
Q4
$1.44M Sell
2,481
-13
-0.5% -$7.35K 0.15% 107
2025
Q3
$1.21M Buy
2,494
+128
+5% +$59.6K 0.13% 126
2025
Q2
$959K Sell
2,366
-42
-2% -$17.6K 0.11% 147
2025
Q1
$1.2M Buy
2,408
+420
+21% +$227K 0.16% 119
2024
Q4
$1.03M Buy
1,988
+13
+0.7% +$7.15K 0.12% 141
2024
Q3
$1.22M Buy
1,975
+1,190
+152% +$704K 0.16% 111
2024
Q2
$434K Buy
785
+299
+62% +$171K 0.06% 240
2024
Q1
$282K Buy
486
+17
+4% +$9.54K 0.05% 298
2023
Q4
$249K Buy
+469
New +$227K 0.05% 298

Other funds holding TMO

Cooper Financial Group's TMO Position: Q2 2026 in Review

Cooper Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, selling an estimated $291K and leaving 2,875 shares worth $1.44M. The position accounts for 0.12% of the portfolio, ranked #129.

Cooper Financial Group first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.71M in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cooper Financial Group held 2,875 shares of Thermo Fisher Scientific worth $1.44M as of Q2 2026.
  • Cooper Financial Group sold 606 Thermo Fisher Scientific shares in Q2 2026, an estimated $291K.
  • Thermo Fisher Scientific made up 0.12% of Cooper Financial Group's portfolio in Q2 2026, its #129 holding.
  • Cooper Financial Group first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Cooper Financial Group's Thermo Fisher Scientific position peaked at $1.71M in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cooper Financial Group's 13F filing for Q2 2026, filed 8 Jul 2026.